US2006178310A1PendingUtilityA1
Intracellular delivery of biological effectors
Est. expiryOct 13, 2020(expired)· nominal 20-yr term from priority
Inventors:Christophe Bonny
A61P 9/04A61P 35/00A61P 5/48A61P 31/12A61P 9/00A61P 3/10A61P 25/00A61P 25/28C07K 2319/00A61K 38/00A61P 11/00C07K 1/047A61K 47/60C07K 5/1013A61K 47/62A61K 47/65C07K 7/06C07K 5/1019Y10S530/81C07K 7/08C07K 5/1021C07K 5/1016
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to sequences of amino acids with the capacity to facilitate transport of an effector across a biological membrane. More specifically, the present invention relates to novel peptide transporters that specifically target certain cell types for the intracellular delivery of drugs and therapeutic agents.
Claims
exact text as granted — not AI-modified1 . A multimeric transporter peptide according to Formula I,
[P] v -[Spacer] x -Core-[Linker] y -[Reporter] z (I)
wherein P is a transporter peptide, comprising at least one amino acid sequence selected from the group consisting of:
a) (X m RX o RX n );
b) (X m RRRX n );
c) (X m RRXRX n ); and
d) (X m RXRRX n ),
wherein
X is a non-basic amino acid;
m is an integer from zero to fourteen;
n is an integer, independent of m, between zero and fourteen;
o is an integer, independent of m and n, between zero and five;
v is an integer from two to eight;
x, y and z, are, independently, zero or one; and
wherein each P can be the same or different, and said transporter peptide is capable of translocating across a biological membrane.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.